Emergency Use of Occlutech® Atrial Flow Regulator Device Facilitates Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation in a Patient With Severe Pulmonary Arterial Hypertension

Abstract

Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Treatment options include anti-PAH medications, continuous intravenous therapies, and diuretics. Lung transplant is required in many cases. Atrial septostomy is an under recognized option in symptomatic patients on maximal PAH therapy. However, creating a sustainable and restrictive atrial communication is challenging with existing devices. We describe emergency use of the Occlutech^® Atrial Flow Regulator, a novel device, in a 35-year-old female with PAH supported on veno-arterial extracorporeal membrane oxygenation after postpartum decompensation.

Keywords

atrial flow regulator extracorporeal membrane oxygenation pulmonary arterial hypertension

Get full access to this article

View all access options for this article.

References

Expanded Access for Medical Devices. U.S. Food and Drug Administration. Published June 21, 2019. Accessed March 29, 2021. https://www.fda.gov/medical-devices/investigational-device-exemption-ide/expanded-access-medical-devices

Patel

Samuel

Girgis

Parlmer

Vettukattil

. Implantable atrial flow regulator for severe, irreversible, pulmonary arterial hypertension. EuroIntervention. 2015;11(6):706–709.

Rajeshkumar

Pavithran

Sivakumar

Vettukattil

. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv. 2017;90(7):1145–1153.

Janus

Sławek-Szmyt

Araszkiewicz

Mularek-Kubzdela

Lesiak

Grygier

. Atrial Flow Regulator as a bridge to lung transplantation in a young patient with drug-resistant idiopathic pulmonary arterial hypertension. Kardiol Pol. 2020;78(5):461–462.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB